Zhengxue Quan Selected Research

Spinal Injuries (Spinal Injury)

12/2020	Midterm surgical results of the lamina with spinous process in treating one-level thoracic or lumbar tuberculosis: a retrospective study.
1/2020	Clinical efficacy of three types of autogenous bone grafts in treatment of single-segment thoracic tuberculosis: A retrospective cohort study.
11/2019	One-stage posterior debridement with transverse process strut as bone graft in the surgical treatment of single-segment thoracic tuberculosis: A retrospective single-center study.
1/2017	[Treatment of multiple segments of thoracolumbar tuberculosis using posterior unilateral debridement with bone graft and internal fixation].
7/2016	[Therapeutic evaluation of intertransverse bone graft for single segmental thoracic spinal tuberculosis].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhengxue Quan Research Topics

Disease

6	Neoplasms (Cancer) 02/2022 - 11/2017
5	Spinal Injuries (Spinal Injury) 12/2020 - 07/2016
5	Spinal Tuberculosis (Pott's Disease) 12/2020 - 01/2018
4	Osteosarcoma (Osteogenic Sarcoma) 06/2022 - 11/2017
4	Kyphosis 03/2022 - 09/2010
4	Osteoporosis 01/2022 - 01/2014
4	Tuberculosis (Tuberculoses) 03/2020 - 07/2016
3	Wounds and Injuries (Trauma) 03/2022 - 01/2017
3	Compression Fractures (Compression Fracture) 03/2022 - 11/2019
3	Hemorrhage 02/2022 - 08/2008
3	Intervertebral Disc Displacement (Herniated Disc) 01/2021 - 01/2011
2	Heart Failure 01/2022 - 01/2021
2	Atrial Fibrillation 01/2022 - 01/2021
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2021
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022 - 01/2021
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2021
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2021
2	Pain (Aches) 04/2021 - 01/2021
2	Infections 01/2021 - 09/2010
2	Congenital Abnormalities (Deformity) 01/2021 - 04/2015
2	Spinal Cord Injuries (Spinal Cord Injury) 04/2019 - 10/2007
2	Cicatrix (Scar) 08/2018 - 05/2007
2	Intervertebral Disc Degeneration 01/2017 - 01/2017
2	Spondylolisthesis 01/2017 - 08/2010
2	Spinal Cord Diseases 01/2016 - 01/2014
1	Discitis 02/2022
1	Brain Ischemia (Cerebral Ischemia) 01/2022
1	Cerebral Hemorrhage 01/2022
1	Osteoporotic Fractures 01/2022
1	Ossification of Posterior Longitudinal Ligament 04/2021
1	Radiculopathy (Radiculopathy, Cervical) 04/2021
1	Lordosis 04/2021
1	Spondylitis 01/2021
1	Hypoalbuminemia 11/2020
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Stroke (Strokes) 01/2020
1	Back Pain (Backache) 09/2019
1	Postoperative Hemorrhage 09/2019
1	Pathologic Constriction (Stenosis) 01/2017
1	Osteomyelitis 12/2016
1	Scoliosis 04/2015

Drug/Important Bio-Agent (IBA)

6	C-Reactive ProteinIBA 01/2021 - 07/2016
5	TitaniumIBA 03/2020 - 04/2010
4	Durapatite (Hydroxylapatite)IBA 12/2016 - 04/2010
4	Nylons (Nylon)IBA 12/2016 - 05/2007
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 06/2022 - 02/2022
2	AdiponectinIBA 01/2022 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2020
2	Celecoxib (Celebrex)FDA Link 01/2021 - 06/2012
2	Capsaicin (Zostrix)FDA Link 10/2018 - 11/2017
1	Photosensitizing Agents (Photosensitizers)IBA 02/2022
1	LigandsIBA 05/2021
1	BilirubinIBA 01/2021
1	MagnesiumIBA 01/2021
1	Bone Cements (Bone Glue)IBA 01/2021
1	Enhancer RNAsIBA 01/2021
1	Ropivacaine (Naropin)FDA LinkGeneric 01/2021
1	Pregabalin (Lyrica)FDA Link 01/2021
1	SteroidsIBA 11/2020
1	Serum AlbuminIBA 11/2020
1	Indicators and Reagents (Reagents)IBA 11/2020
1	troxerutinIBA 01/2020
1	Biological ProductsIBA 01/2020
1	Competitive Endogenous RNAIBA 04/2019
1	Cisplatin (Platino)FDA LinkGeneric 10/2018
1	PhytochemicalsIBA 10/2018
1	Protein Kinases (Protein Kinase)IBA 11/2017
1	Antineoplastic Agents (Antineoplastics)IBA 11/2017
1	Bone Morphogenetic Protein 2IBA 01/2017
1	L 644711 (B-3(+))IBA 01/2017
1	Tranexamic Acid (AMCA)FDA Link 01/2017
1	SilverIBA 12/2016
1	IonsIBA 12/2016
1	Therapeutic UsesIBA 12/2016
1	Local Anti-Infective Agents (Antiseptics)IBA 12/2016
1	Biocompatible Materials (Biomaterials)IBA 12/2016
1	Genetic Markers (Genetic Marker)IBA 01/2014
1	OsteoprotegerinIBA 01/2014
1	Collagen Type II (Type II Collagen)IBA 06/2012
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 06/2012

Therapy/Procedure

9	Debridement 02/2022 - 09/2010
7	Therapeutics 02/2022 - 04/2010
4	Laminectomy 04/2021 - 01/2011
3	Length of Stay 02/2022 - 09/2019
3	Diskectomy (Discectomy) 04/2013 - 04/2010
2	Osteotomy 03/2022 - 04/2015
2	Vertebroplasty 01/2021 - 11/2019
2	Pedicle Screws 11/2019 - 08/2010
2	Operative Time 09/2019 - 02/2010
2	Decompression 04/2015 - 04/2010
1	Photochemotherapy (Photodynamic Therapy) 02/2022
1	Foraminotomy 04/2021
1	Analgesia 01/2021
1	Injections 01/2020
1	Bone Transplantation (Bone Grafting) 09/2019
1	Drug Therapy (Chemotherapy) 10/2018
1	Punctures 01/2017
1	Contraindications 04/2013